When the heart is injured or strained, molecules called Cardiac Biomarkers are released into the bloodstream.
Cardiac Biomarkers Cardiac Biomarkers are used to diagnose and risk stratify patients with chest discomfort and suspected acute coronary syndrome (ACS), as well as to treat and predict outcomes in patients with acute heart failure, pulmonary embolism, and other diseases. A cardiac biomarker is a protein-based molecule that may be measured for heart disease prognosis and diagnosis. When the heart is injured or stressed, such as from a lack of oxygen, cardiac biomarkers are released into the bloodstream. Cardiovascular biomarkers including cardiac troponin, creatinine kinase, myoglobin, and others are used to diagnose disorders like ACS and heart ischemia. According to Coherent Market Insights, The global Cardiac Biomarker Market is estimated to be valued at US$ 8,099.9 Mn in 2021 and is expected to exhibit a CAGR of 10.2% during the forecast period (2021-2028). Cardiac biomarkers are protein molecules released into the bloodstream as a result of cardiac injury or stre...